In a report released today, Andy Hsieh from William Blair maintained a Buy rating on Skye Bioscience (SKYE – Research Report). The company’s ...

The original musical “Why Can’t They See?”, written by Pastor Bill Blair, will be presented at 7 p.m. on Maundy Thursday, ...

In a report released today, Matt Larew from William Blair maintained a Buy rating on 908 Devices (MASS – Research Report). The company’s shares opened today at $4.43. Discover outperforming ...

CEO Stephen Squeri said current strategy will continue, adding it would look to adjust expenses in areas such as marketing if ...

An investigation into the national security implications of pharma imports has been underway for two weeks, the Trump ...

American Airlines announced that loyalty members will have access to free high-speed satellite WiFi from next January.

Ulta, once a lightning rod for growth, has reached a different stage in its life. At the same time, online sales channels ...

Bristol Myers Squibb’s examination into whether its heart med Camzyos can spark improvements in patients with non-obstructive ...

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on OneMain Holdings (OMF – Research Report), ...

Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Apellis Pharmaceuticals (APLS – Research Report) today and set a ...

William Blair Growth Fd earns a Below Average Process Pillar rating. The process benefits from the stability of the management team. Specifically, the fund has not seen a manager change in the ...